Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,528.60
+41.70 (1.68%)
Jul 3, 2026, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.04 trillion as of July 2, 2026. Its market cap has increased by 5.87% in one year.
Market Cap
1.04T
Enterprise Value
1.09T
Revenue
142.78B
Ranking
n/a
PE Ratio
54.64
Stock Price
2,528.60
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.04T, an increase of 83.29%. That is a compound annual growth rate of 21.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 1.04T | 15.17% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.79T |
| Cipla | 1.18T |
| Zydus Lifesciences | 1.14T |
| Aurobindo Pharma | 932.40B |
| Laurus Labs | 832.62B |
| Alkem Laboratories | 665.08B |
| Glenmark Pharmaceuticals | 623.95B |
| Ipca Laboratories | 451.31B |